| R-HSA-109581 |
Apoptosis |
| R-HSA-1168372 |
Downstream signaling events of B Cell Receptor (BCR) |
| R-HSA-1169091 |
Activation of NF-kappaB in B cells |
| R-HSA-1234174 |
Cellular response to hypoxia |
| R-HSA-1234176 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha |
| R-HSA-1236974 |
ER-Phagosome pathway |
| R-HSA-1236975 |
Antigen processing-Cross presentation |
| R-HSA-1236975 |
Antigen processing-Cross presentation |
| R-HSA-1236978 |
Cross-presentation of soluble exogenous antigens (endosomes) |
| R-HSA-1257604 |
PIP3 activates AKT signaling |
| R-HSA-1266738 |
Developmental Biology |
| R-HSA-1280215 |
Cytokine Signaling in Immune system |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-1430728 |
Metabolism |
| R-HSA-157118 |
Signaling by NOTCH |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-162906 |
HIV Infection |
| R-HSA-162909 |
Host Interactions of HIV factors |
| R-HSA-1640170 |
Cell Cycle |
| R-HSA-1643685 |
Disease |
| R-HSA-168249 |
Innate Immune System |
| R-HSA-168256 |
Immune System |
| R-HSA-168256 |
Immune System |
| R-HSA-169911 |
Regulation of Apoptosis |
| R-HSA-174084 |
Autodegradation of Cdh1 by Cdh1:APC/C |
| R-HSA-174113 |
SCF-beta-TrCP mediated degradation of Emi1 |
| R-HSA-174143 |
APC/C-mediated degradation of cell cycle proteins |
| R-HSA-174154 |
APC/C:Cdc20 mediated degradation of Securin |
| R-HSA-174178 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| R-HSA-174184 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A |
| R-HSA-176408 |
Regulation of APC/C activators between G1/S and early anaphase |
| R-HSA-176409 |
APC/C:Cdc20 mediated degradation of mitotic proteins |
| R-HSA-176814 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins |
| R-HSA-179419 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint |
| R-HSA-180534 |
Vpu mediated degradation of CD4 |
| R-HSA-180585 |
Vif-mediated degradation of APOBEC3G |
| R-HSA-187577 |
SCF(Skp2)-mediated degradation of p27/p21 |
| R-HSA-195253 |
Degradation of beta-catenin by the destruction complex |
| R-HSA-195721 |
Signaling by WNT |
| R-HSA-201681 |
TCF dependent signaling in response to WNT |
| R-HSA-202403 |
TCR signaling |
| R-HSA-202424 |
Downstream TCR signaling |
| R-HSA-211733 |
Regulation of activated PAK-2p34 by proteasome mediated degradation |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-2262752 |
Cellular responses to stress |
| R-HSA-2454202 |
Fc epsilon receptor (FCERI) signaling |
| R-HSA-2467813 |
Separation of Sister Chromatids |
| R-HSA-2555396 |
Mitotic Metaphase and Anaphase |
| R-HSA-2871837 |
FCERI mediated NF-kB activation |
| R-HSA-349425 |
Autodegradation of the E3 ubiquitin ligase COP1 |
| R-HSA-350562 |
Regulation of ornithine decarboxylase (ODC) |
| R-HSA-351202 |
Metabolism of polyamines |
| R-HSA-376176 |
Signaling by ROBO receptors |
| R-HSA-382551 |
Transport of small molecules |
| R-HSA-382556 |
ABC-family proteins mediated transport |
| R-HSA-3858494 |
Beta-catenin independent WNT signaling |
| R-HSA-392499 |
Metabolism of proteins |
| R-HSA-4086400 |
PCP/CE pathway |
| R-HSA-422475 |
Axon guidance |
| R-HSA-446652 |
Interleukin-1 family signaling |
| R-HSA-449147 |
Signaling by Interleukins |
| R-HSA-450408 |
AUF1 (hnRNP D0) binds and destabilizes mRNA |
| R-HSA-450531 |
Regulation of mRNA stability by proteins that bind AU-rich elements |
| R-HSA-453274 |
Mitotic G2-G2/M phases |
| R-HSA-453276 |
Regulation of mitotic cell cycle |
| R-HSA-453279 |
Mitotic G1 phase and G1/S transition |
| R-HSA-4608870 |
Asymmetric localization of PCP proteins |
| R-HSA-4641257 |
Degradation of AXIN |
| R-HSA-4641258 |
Degradation of DVL |
| R-HSA-5357801 |
Programmed Cell Death |
| R-HSA-5358346 |
Hedgehog ligand biogenesis |
| R-HSA-5358351 |
Signaling by Hedgehog |
| R-HSA-5358351 |
Signaling by Hedgehog |
| R-HSA-5362768 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD |
| R-HSA-5387390 |
Hh mutants abrogate ligand secretion |
| R-HSA-5607761 |
Dectin-1 mediated noncanonical NF-kB signaling |
| R-HSA-5607764 |
CLEC7A (Dectin-1) signaling |
| R-HSA-5610780 |
Degradation of GLI1 by the proteasome |
| R-HSA-5610783 |
Degradation of GLI2 by the proteasome |
| R-HSA-5610785 |
GLI3 is processed to GLI3R by the proteasome |
| R-HSA-5610787 |
Hedgehog 'off' state |
| R-HSA-5610787 |
Hedgehog 'off' state |
| R-HSA-5619084 |
ABC transporter disorders |
| R-HSA-5619115 |
Disorders of transmembrane transporters |
| R-HSA-5621481 |
C-type lectin receptors (CLRs) |
| R-HSA-5632684 |
Hedgehog 'on' state |
| R-HSA-5658442 |
Regulation of RAS by GAPs |
| R-HSA-5663202 |
Diseases of signal transduction by growth factor receptors and second messengers |
| R-HSA-5663205 |
Infectious disease |
| R-HSA-5668541 |
TNFR2 non-canonical NF-kB pathway |
| R-HSA-5673001 |
RAF/MAP kinase cascade |
| R-HSA-5676590 |
NIK-->noncanonical NF-kB signaling |
| R-HSA-5678895 |
Defective CFTR causes cystic fibrosis |
| R-HSA-5683057 |
MAPK family signaling cascades |
| R-HSA-5684996 |
MAPK1/MAPK3 signaling |
| R-HSA-5687128 |
MAPK6/MAPK4 signaling |
| R-HSA-5688426 |
Deubiquitination |
| R-HSA-5689603 |
UCH proteinases |
| R-HSA-5689880 |
Ub-specific processing proteases |
| R-HSA-5689901 |
Metalloprotease DUBs |
| R-HSA-597592 |
Post-translational protein modification |
| R-HSA-6798695 |
Neutrophil degranulation |
| R-HSA-6807070 |
PTEN Regulation |
| R-HSA-68827 |
CDT1 association with the CDC6:ORC:origin complex |
| R-HSA-68867 |
Assembly of the pre-replicative complex |
| R-HSA-68882 |
Mitotic Anaphase |
| R-HSA-68886 |
M Phase |
| R-HSA-68949 |
Orc1 removal from chromatin |
| R-HSA-69002 |
DNA Replication Pre-Initiation |
| R-HSA-69017 |
CDK-mediated phosphorylation and removal of Cdc6 |
| R-HSA-69052 |
Switching of origins to a post-replicative state |
| R-HSA-69202 |
Cyclin E associated events during G1/S transition |
| R-HSA-69206 |
G1/S Transition |
| R-HSA-69239 |
Synthesis of DNA |
| R-HSA-69242 |
S Phase |
| R-HSA-69275 |
G2/M Transition |
| R-HSA-69278 |
Cell Cycle, Mitotic |
| R-HSA-69306 |
DNA Replication |
| R-HSA-69481 |
G2/M Checkpoints |
| R-HSA-69541 |
Stabilization of p53 |
| R-HSA-69563 |
p53-Dependent G1 DNA Damage Response |
| R-HSA-69580 |
p53-Dependent G1/S DNA damage checkpoint |
| R-HSA-69601 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A |
| R-HSA-69610 |
p53-Independent DNA Damage Response |
| R-HSA-69613 |
p53-Independent G1/S DNA damage checkpoint |
| R-HSA-69615 |
G1/S DNA Damage Checkpoints |
| R-HSA-69620 |
Cell Cycle Checkpoints |
| R-HSA-69656 |
Cyclin A:Cdk2-associated events at S phase entry |
| R-HSA-71291 |
Metabolism of amino acids and derivatives |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-75815 |
Ubiquitin-dependent degradation of Cyclin D |
| R-HSA-8852276 |
The role of GTSE1 in G2/M progression after G2 checkpoint |
| R-HSA-8854050 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis |
| R-HSA-8878159 |
Transcriptional regulation by RUNX3 |
| R-HSA-8878166 |
Transcriptional regulation by RUNX2 |
| R-HSA-8878166 |
Transcriptional regulation by RUNX2 |
| R-HSA-8878171 |
Transcriptional regulation by RUNX1 |
| R-HSA-8939236 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs |
| R-HSA-8939902 |
Regulation of RUNX2 expression and activity |
| R-HSA-8939902 |
Regulation of RUNX2 expression and activity |
| R-HSA-8941858 |
Regulation of RUNX3 expression and activity |
| R-HSA-8948751 |
Regulation of PTEN stability and activity |
| R-HSA-8951664 |
Neddylation |
| R-HSA-8953854 |
Metabolism of RNA |
| R-HSA-8953897 |
Cellular responses to external stimuli |
| R-HSA-9006925 |
Intracellular signaling by second messengers |
| R-HSA-9010553 |
Regulation of expression of SLITs and ROBOs |
| R-HSA-9013694 |
Signaling by NOTCH4 |
| R-HSA-9020702 |
Interleukin-1 signaling |
| R-HSA-9604323 |
Negative regulation of NOTCH4 signaling |
| R-HSA-9607240 |
FLT3 Signaling |
| R-HSA-9675108 |
Nervous system development |
| R-HSA-983168 |
Antigen processing: Ubiquitination & Proteasome degradation |
| R-HSA-983169 |
Class I MHC mediated antigen processing & presentation |
| R-HSA-983169 |
Class I MHC mediated antigen processing & presentation |
| R-HSA-983705 |
Signaling by the B Cell Receptor (BCR) |
